For countless individuals, the workday commences long before natural light appears, often before their brains are naturally primed for activity. A recent clinical trial has revealed that solriamfetol, a medication specifically designed to promote wakefulness, can significantly enhance alertness among early-morning shift workers who struggle with shift work disorder (SWD).
Participants in the study who took the drug demonstrated improved wakefulness and better functional capabilities throughout their entire shifts. These improvements led to tangible benefits in various aspects, including increased productivity, enhanced workplace safety, and better overall daily performance.